MedPath

Outpatient Induction of Labour Using Intracervical Foley Catheter

Not Applicable
Terminated
Conditions
Induction of Labor Affected Fetus / Newborn
Pregnancy Related
Interventions
Drug: Intravaginal prostaglandin E2
Device: Foley catheter
Registration Number
NCT05622968
Lead Sponsor
Hospital Kemaman
Brief Summary

Prospective quasi-experimental study between a study population who will receive outpatient induction of labour using intracervical Foley catheter, followed by the inpatient induction using intravaginal prostaglandin and a control group of women with similar characteristics undergoing inpatient labour induction with intravaginal prostaglandin (standard management)

Detailed Description

The study will be conducted among pregnant women in 2 to 5th pregnancy who have no significant risk factors and planned for induction of labour. The eliiable women will be recruited from 4 health clinics within the district (of Kemaman, Malaysia) and located within 20 km from the hospital.

Willing participants will be seen in the hospital at the planned induction date and reassessed. Should they be suitable for induction of labour using Foley catheter on outpatient basis, a 18G Foley catheter will be inserted into the cervical canal and the balloon inflated with sterile water (60 mls). The fetal well being will be assessed and the women allowed to go home with instruction related to the induction and the study.

Those who do not enter the active phase of labour will be admitted to the ward 24 hours later and will undergo inpatient induction of labour using intravaginal prostaglandin (Dinoprostone) according to the local protocol.

These women will be compared with a control group comprising of women with similar characteristics and undergo inpatient induction of labour with intravaginal Dinoprostone.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Age > 18 year old
  • Singleton pregnancy
  • Cephalic presentation
  • Multiparous women in their 2nd to 5th pregnancy (Para 1 to 4)
  • Gestational age between 37+0 and 41+0 weeks.
  • No previous uterine surgery (lower segment caesarean section, upper segment caesarean section, myomectomy
  • Resides within 30 minutes drive from Hospital Kemaman
  • Has access to a telephone
  • Has reliable transportation (i.e. able to get to the hospital immediately without the need of ambulance)
  • Acceptance of participation by the signing of a written consent.
Exclusion Criteria
  • Pregnancy with non-cephalic presentation
  • Prior cesarean delivery
  • Gestational hypertension or preeclampsia on 2 or more medications
  • Diabetes in pregnancy on high dose medication(s); insulin of more than 60 units per day or combination of insulin and oral hypoglycemic agent
  • Low lying placenta or placenta praevia
  • Rupture of amniotic membrane
  • Primiparae and grandmultiparae (para 5 or more)
  • Multiple pregnancy
  • Fetal death
  • Fetal anomalies: defined as the presence of a major fetal anomaly of any organ system
  • Fetal growth restriction: defined as an ultrasound derived estimated fetal weight less than the 10th percentile for gestational age
  • Suspected macrosomia: defined as an ultrasound derived estimated fetal weight of more than 90th centile for gestational age
  • Oligohydramnios: ultrasound measured amniotic fluid index (AFI) less than the 10th percentile for gestational age
  • Polyhydramnios: defined as an AFI of 24 cm or greater or a single deepest vertical pocket of 8 cm or greater
  • Latex allergy
  • Contraindication to induction of labor
  • Evidence of active phase of labor

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlIntravaginal prostaglandin E2Women who are planned for elective delivery for obstetric indication(s) and undergo inpatient induction of labour using intravaginal prostaglandin
InterventionFoley catheterWomen who are planned for elective delivery for obstetric indication(s) and undergo outpatient induction of labour using Foley catheter
InterventionIntravaginal prostaglandin E2Women who are planned for elective delivery for obstetric indication(s) and undergo outpatient induction of labour using Foley catheter
Primary Outcome Measures
NameTimeMethod
Induction of labour-delivery intervalInduction of labour (intravaginal prostaglandin) to delivery

The mean interval between the start of inpatient cervical ripening and delivery (from the start of cervical ripening with Dinoprostone to the delivery of the baby)

Secondary Outcome Measures
NameTimeMethod
Incidence of chorioamnionitisInduction to 24 hours after delivery

maternal temperature is greater than or equal to 39.0°C or when the maternal temperature is 38.0-38.9°C and one additional clinical risk factor is present

Labour augmentationInduction to delivery

Duration and maximum oxytocin dose used for labour augmentation

Analgesia requirementInduction to delivery

Prevalence of analgesia required during induction of labour

Neonatal complicationDelivery to 24 hours after birth

Admission to the Neonatal Intensive Care Unit

Success rate of induction of labour within 12 hoursFrom the start of inpatient cervical ripening and delivery

The percentage of vaginal delivery within 12 hours of inpatient cervical ripening

Success rate of induction of labour within 24 hoursFrom the start of inpatient cervical ripening and delivery

The percentage of vaginal delivery within 24 hours of inpatient cervical ripening

Adverse eventInduction to delivery

Incidence of uterine tachysystole and hyperstimulation

Neonatal Apgar scoreDelivery to 10 minutes after birth

Incidence of low Apgar score (less than 7) at 5 minutes after delivery

Delivery outcomeInduction to delivery

Percentage of caesarean section and instrumental delivery

Maximum pain recordedInduction to delivery

Maximum recorded contraction pain during cervical ripening (using Visual Analogue Scale of 10)

Postpartum hemorrhageDelivery to 24 hours after delivery

Primary postpartum haemorrhage (blood loss of more than 500mls within 24 hours of delivery)

Neonatal intubationDelivery to 30 minutes after birth

Incidence of neonates requiring intubation

Neonatal seizureDelivery to 24 hours after birth

Incidence of neonate with seizure

Trial Locations

Locations (1)

Hospital Kemaman

🇲🇾

Kampong Kemaman, Terengganu, Malaysia

© Copyright 2025. All Rights Reserved by MedPath